Latest Insider Transactions at Pluristem Therapeutics Inc (PSTI)
This section provides a real-time view of insider transactions for Pluristem Therapeutics Inc (PSTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PLURISTEM THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PLURISTEM THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2024
|
Chen Franco Yehuda Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,413
+11.08%
|
-
|
|
Sep 18
2024
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,240
+7.05%
|
-
|
|
Jan 23
2024
|
Lorne Kenneth Abony Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,750
+50.0%
|
-
|
|
Jan 23
2024
|
Rami Avraham Levi Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,100
+39.38%
|
-
|
|
Jan 23
2024
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
700,000
+22.15%
|
-
|
|
Jan 23
2024
|
Maital Shemesh Rasmussen Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,150
+39.62%
|
-
|
|
Jan 23
2024
|
Pinhas Doron Birger Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,900
+39.98%
|
-
|
|
Jan 23
2024
|
Zami Aberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,100
+2.79%
|
-
|
|
Jan 23
2024
|
Chen Franco Yehuda Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
355,000
+42.89%
|
-
|
|
Dec 22
2022
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
334,821
+15.98%
|
-
|
|
Dec 20
2022
|
Zami Aberman Director |
SELL
Open market or private sale
|
Direct |
2,000
-0.13%
|
$0
$0.97 P/Share
|
|
Feb 10
2022
|
Zami Aberman Director |
BUY
Open market or private purchase
|
Indirect |
80,616
+46.77%
|
$80,616
$1.8 P/Share
|
|
Jul 15
2021
|
Pinhas Doron Birger Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jul 15
2021
|
Varda Shalev Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
May 28
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
115,007
-1.79%
|
$345,021
$3.72 P/Share
|
|
May 27
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
95,885
-1.45%
|
$287,655
$3.69 P/Share
|
|
May 26
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
144,678
-2.09%
|
$434,034
$3.69 P/Share
|
|
May 25
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
261,238
-6.99%
|
$783,714
$3.84 P/Share
|
|
May 24
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
79,300
-2.08%
|
$237,900
$3.83 P/Share
|
|
May 21
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
69,838
-1.8%
|
$209,514
$3.98 P/Share
|
|
May 03
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
23,721
-0.61%
|
$94,884
$4.28 P/Share
|
|
Apr 30
2021
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
166,004
-4.07%
|
$664,016
$4.66 P/Share
|
|
Jan 05
2021
|
Rami Avraham Levi Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jan 05
2021
|
Maital Shemesh Rasmussen Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Nov 30
2020
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
20,000
+0.49%
|
$180,000
$9.7 P/Share
|
|
Oct 30
2020
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
50,000
+0.61%
|
$450,000
$9.51 P/Share
|
|
Oct 29
2020
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
20,000
+0.5%
|
$180,000
$9.2 P/Share
|
|
Sep 30
2020
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
139,006
+3.37%
|
$1,390,060
$10.34 P/Share
|
|
Sep 29
2020
|
Clover Wolf Capital Limited Partnership > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
60,123
+1.54%
|
$541,107
$9.76 P/Share
|